Telmisartan/Hydrochlorotiazid Accord 80 mg/25 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

telmisartan/hydrochlorotiazid accord 80 mg/25 mg tablety

accord healthcare polska sp. z o.o., poľsko - telmisartan a diuretiká - 58 - hypotensiva

Telmisartan/Hydrochlorotiazid Accord 80 mg/12,5 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

telmisartan/hydrochlorotiazid accord 80 mg/12,5 mg tablety

accord healthcare polska sp. z o.o., poľsko - telmisartan a diuretiká - 58 - hypotensiva

Telmisartan/Hydrochlorotiazid Accord 40 mg/12,5 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

telmisartan/hydrochlorotiazid accord 40 mg/12,5 mg tablety

accord healthcare polska sp. z o.o., poľsko - telmisartan a diuretiká - 58 - hypotensiva

Telhycar 80 mg/25 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

telhycar 80 mg/25 mg tablety

swyssi ag, nemecko - telmisartan a diuretiká - 58 - hypotensiva

Telhycar 80 mg/12,5 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

telhycar 80 mg/12,5 mg tablety

swyssi ag, nemecko - telmisartan a diuretiká - 58 - hypotensiva

Teriflunomide Mylan Európska únia - slovenčina - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Európska únia - slovenčina - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresívami, selektívne imunosupresívami - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Bozilos Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bozilos

egis pharmaceuticals plc, maďarsko - teriflunomid - 59 - immunopraeparata

Tibsovo Európska únia - slovenčina - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastické činidlá - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Teriflunomide Stada 14 mg filmom obalené tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

teriflunomide stada 14 mg filmom obalené tablety

stada arzneimittel ag, nemecko - teriflunomid - 59 - immunopraeparata